User profiles for A. Swart

Arno Swart

RIVM
Verified email at rivm.nl
Cited by 2336

[HTML][HTML] Atmospheric dispersion modelling of bioaerosols that are pathogenic to humans and livestock–A review to inform risk assessment studies

JPG Van Leuken, AN Swart, AH Havelaar… - Microbial Risk …, 2016 - Elsevier
In this review we discuss studies that applied atmospheric dispersion models (ADM) to
bioaerosols that are pathogenic to humans and livestock in the context of risk assessment studies…

Prognostic relevance of uncommon ovarian histology in women with stage III/IV epithelial ovarian cancer

…, A Reuss, E Pujade-Lauraine, AM Swart… - International Journal of …, 2010 - ijgc.bmj.com
Background: The prognostic relevance of uncommon epithelial ovarian cancer (EOC)
histological subtypes remains controversial. The Gynecologic Cancer InterGroup (GCIG) initiated …

Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial

…, J Herod, G McCluggage, M Parmar, AM Swart - The Lancet, 2015 - thelancet.com
Background The international standard of care for women with suspected advanced ovarian
cancer is surgical debulking followed by platinum-based chemotherapy. We aimed to …

[HTML][HTML] Acanthamoeba and Dictyostelium as Cellular Models for Legionella Infection

AL Swart, CF Harrison, L Eichinger… - Frontiers in cellular …, 2018 - frontiersin.org
Environmental bacteria of the genus Legionella naturally parasitize free-living amoebae.
Upon inhalation of bacteria-laden aerosols, the opportunistic pathogens grow intracellularly in …

[HTML][HTML] Seroprevalence and risk factors for Toxoplasma gondii infection in domestic cats in The Netherlands

M Opsteegh, R Haveman, AN Swart… - Preventive Veterinary …, 2012 - Elsevier
Cats, as definitive hosts, play an important role in the transmission of Toxoplasma gondii. To
determine the seroprevalence and risk factors for T. gondii infection in Dutch domestic cats, …

[HTML][HTML] Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomised trial

…, C Mediola, C Coens, W Qian, MKB Parmar, AM Swart - The Lancet, 2010 - thelancet.com
Background Serum CA125 concentration often rises several months before clinical or
symptomatic relapse in women with ovarian cancer. In the MRC OV05/EORTC 55955 …

[HTML][HTML] A phase 3 trial of bevacizumab in ovarian cancer

TJ Perren, AM Swart, J Pfisterer… - … England Journal of …, 2011 - Mass Medical Soc
Background Angiogenesis plays a role in the biology of ovarian cancer. We examined the
effect of bevacizumab, the vascular endothelial growth factor inhibitor, on survival in women …

Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study.

H Kitchener, AM Swart, Q Qian, C Amos… - Lancet (London …, 2008 - europepmc.org
Background Hysterectomy and bilateral salpingo-oophorectomy (BSO) is the standard
surgery for stage I endometrial cancer. Systematic pelvic lymphadenectomy has been used to …

[HTML][HTML] Perioperative strategy in colonic surgery; LA paroscopy and/or FA st track multimodal management versus standard care (LAFA trial)

…, WF van Tets, BA van Wagensveld, A Swart… - BMC surgery, 2006 - Springer
Background Recent developments in large bowel surgery are the introduction of laparoscopic
surgery and the implementation of multimodal fast track recovery programs. Both focus on …

[HTML][HTML] Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 …

…, T Ehlen, GC Jayson, N Johnson, AM Swart… - The Lancet …, 2018 - thelancet.com
Background Individual patient data from two randomised trials comparing neoadjuvant
chemotherapy with upfront debulking surgery in advanced tubo-ovarian cancer were analysed to …